These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites. Arias HR; Ortells MO; Feuerbach D Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645 [TBL] [Abstract][Full Text] [Related]
13. Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors. Arias HR; Feuerbach D; Ortells MO Neurochem Int; 2016 Nov; 100():67-77. PubMed ID: 27612850 [TBL] [Abstract][Full Text] [Related]
14. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms. Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208 [TBL] [Abstract][Full Text] [Related]
15. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel. Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW Int J Biochem Cell Biol; 2010 Jun; 42(6):1007-18. PubMed ID: 20223294 [TBL] [Abstract][Full Text] [Related]
16. Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABA Tae HS; Ortells MO; Yousuf A; Xu SQ; Akk G; Adams DJ; Arias HR Biochem Pharmacol; 2024 May; 223():116183. PubMed ID: 38580167 [TBL] [Abstract][Full Text] [Related]
17. Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake. López-Valdés HE; García-Colunga J Mol Psychiatry; 2001 Sep; 6(5):511-9. PubMed ID: 11526465 [TBL] [Abstract][Full Text] [Related]
18. Functional and structural interaction of (-)-lobeline with human α4β2 and α4β4 nicotinic acetylcholine receptor subtypes. Arias HR; Feuerbach D; Ortells M Int J Biochem Cell Biol; 2015 Jul; 64():15-24. PubMed ID: 25794424 [TBL] [Abstract][Full Text] [Related]
19. Molecular Determinants of α3β4 Nicotinic Acetylcholine Receptors Inhibition by Triterpenoids. Eom S; Kim YS; Lee SB; Noh S; Yeom HD; Bae H; Lee JH Biol Pharm Bull; 2018; 41(1):65-72. PubMed ID: 29311484 [TBL] [Abstract][Full Text] [Related]